On a roll, Sanofi and Regeneron’s Dupixent scores again in second COPD trial kdunleavy Mon, 11/27/2023 – 09:55 More: On a roll, Sanofi and Regeneron's Dupixent scores again in second COPD trial Source: fierce
read moreNovo Nordisk keeps GLP-1 expansion spree rolling with $2.3B manufacturing upgrade in France fkansteiner Mon, 11/27/2023 – 08:45 More: Novo Nordisk keeps GLP-1 expansion spree rolling with .3B manufacturing upgrade in France Source: fierce
read moreThe IRP will bring life-saving medicines to UK patients from 1 January 2024 More: MHRA launches online eligibility checker tool via the IRP Source: News
read moreAround £330m will be invested in the software over the next seven years More: New NHS software set to improve care for millions of patients Source: News
read moreThe findings could benefit patients living with neurodegenerative conditions More: Study suggests cognitive decline could be linked to hippocampus shrinkage Source: News
read moreAround 3,200 new cases of cervical cancer are diagnosed in the UK every year More: NHS urges individuals to take up cervical screening invitations Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals